Hidradenitis Suppurativa Market Research Report - Global Forecast till 2027

Global Hidradenitis Suppurativa Market information, by skin conditions (pimples, folliculitis, deep-acne like cysts and blackheads, boils, and and others), by treatment (medications, surgery, and others), by end user- Forecast till 2027

ID: MRFR/Pharma/2497-HCR | February 2021 | Region: Global | 68 pages

Please note that the assessment period of report has been updated from 2016- 2023 to 2020-2027. Cordially fill Sample form for updated data.

Market synopsis of global hidradenitis suppurativa market:

Market Scenario:

Hidradenitis suppurativa is a rare, inflammatory skin condition that begins as small and painful pimples on the skin. This medical condition is most common between the ages of 20-40 years. Prevalence of hidradenitis suppurativa is three times more common in females than in males.

Increasing cases of various skin diseases are key driver for the global hidradenitis suppurativa market. FDA (U.S. Food and Drug Administration) approvals for drugs and clinical trials are major factor for the growth of the market. Over the past few years, due to increasing knowledge of the disease, and introduction of new drugs and treatment options, the market is continuously growing.

The Global hidradenitis suppurativa market is growing at the CAGR of ~4.2% during the forecast period and expected to reach US$ 763.6 million by 2023.

Study objectives of Global Hidradenitis Suppurativa Market:

  • To provide detailed analysis of the global hidradenitis suppurativa market structure with historical and forecast revenue for the next 6 years of the various segments and sub-segments.

  • To provide insights about the key drivers, restraints, opportunities and challenges affecting the growth of global hidradenitis suppurativa market

  • To provide analysis of the market with respect to four main geographies and their countries – the Americas, Europe, Asia-Pacific, and Middle East & Africa.

  • To provide detailed analysis of the market segmented by skin conditions, treatment, end user, and its sub-segments.

  • To provide a detailed analysis of global hidradenitis suppurativa market mainly based on Value chain analysis, Porter’s five forces, Price analysis, and Supply Chain analysis etc.

  • To provide a detailed country level analysis of the market with respect to the current market size and future prospects.

  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global hidradenitis suppurativa market

  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the hidradenitis suppurativa market



Sources: American Academy of Dermatology, U.S. National Library of Medicine, The Irish Skin Foundation, National Center for Biotechnology Information (NCBI), National Organization for Rare Disorders, Inc., Directorate of Industries, Annual report, White paper, Company Presentation

 Key Players for Global Hidradenitis suppurativa market:                          

Some of the key players in this market are: AbbVie Inc. (US), Allergan (Republic of Ireland), AstraZeneca (UK), GlaxoSmithKline plc. (UK), Johnson & Johnson Services, Inc. (US), Merck & Co., Inc. (US), Pfizer Inc.(US), and others


Global Hidradenitis suppurativa market has been segmented on the basis of skin conditions which comprises of pimples, folliculitis, deep-acne, boils, and, and others. Folliculitis is further sub-segmented into bacterial folliculitis, hot tub folliculitis (pseudomonas folliculitis), barber's itch (pseudofolliculitis barbae), pityrosporum folliculitis, and others. Deep-acne is further sub-segmented into cysts, blackheads, and others. Boils are further sub-segmented into furuncle or carbuncle, cystic acne, pilondial cyst, and others.

On the basis of treatment, the market has been segmented into medications, surgery, laser treatment, Photodynamic Therapy (PDT), and others. Medication is further sub-segmented into antibiotics, antiandrogens, immunosuppressive-drugs-market-8228'>Immunosuppressive drugs, hormones, pain medication, Zinc supplements, sulphones, retinoids, and others. Surgery is further sub-segmented into Punch debridement, Incision and drainage, surgical removal, issue-sparing excision with electrosurgery, and others.

On the basis of end user, it is segmented into hospitals, dermatology clinics, medical research centers, academic institutes, and others.

Research Methodology: 

Sources: American Academy of Dermatology, U.S. National Library of Medicine, The Irish Skin Foundation, National Center for Biotechnology Information (NCBI), Nati
onal Organization for Rare Disorders, Inc., Directorate of Industries, Annual report, White paper, Company Presentation

Regional analysis of global hidradenitis suppurativa Market:              

Considering the global scenario of the market, North America holds the largest market share due to various factors such as increasing cases of skin diseases and related medical complications. European hidradenitis suppurativa market is the second largest where the west European countries like Germany, France, and UK are holding the largest market share. Prevalence of hidradenitis suppurativa is continuously increasing in Asia Pacific region. Additionally, developing healthcare infrastructure and facilities, affordable healthcare, government initiatives to improve public health and rising healthcare expenditure are driving the growth for Asia Pacific hidradenitis suppurativa market. Due to low knowledge of disease, limited access to healthcare facilities, Middle East and Africa (ME&A) is likely to have a limited growth in the market.
The report for Global Hidradenitis Suppurativa Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain deeper insight to the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions.
Intended Audience:

  • Hidradenitis Suppurativa medicines manufacturers

  • Hidradenitis Suppurativa medicine and treatment providers

  • Hospitals and clinics

  • Medical Research laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors

Frequently Asked Questions (FAQ) :

The Predicted CAGR would be 4.2% During The Forecast Period of 2018 to 2023.

The FDA Approval Rate For Drugs And Treatment Would Trigger Market Growth.

The Market Valuation would be USD 763.3 Million.

The End Users Are Medical Research Centers, Dermatology Clinics, Hospitals, Academic Institutes, And Others.

The North American Hidradenitis Suppurativa Market has the upper hand.

1. Report Prologue

2. Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

2.3 Market Structure

2.4. Market Segmentation

3. Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

3.5 Forecast Model

4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Mega Trends

4.5 Macroeconomic Indicators

5. Market Factor analysis

5.1 Value Chain Analysis

5.2 Porters Five Forces

5.3 Demand & Supply: Gap Analysis

5.4 Pricing Analysis

5.5 Investment Opportunity Analysis

5.6 Merger and Acquisition Landscape

5.7 Upcoming trends

5.7.1 Market trends

5.7.2 Technological trends

5.7.3 Insurance & Regulations

5.7.4 Others

6. Global Hidradenitis Suppurativa Market By Skin Conditions

6.1 Pimples

6.2 Folliculitis

6.2.1 Bacterial folliculitis

6.2.2 Hot tub folliculitis (pseudomonas folliculitis)

6.2.3 Barber's itch (pseudofolliculitis barbae)

6.2.4 Pityrosporum folliculitis

6.2.5 Others

6.3 Deep-acne

6.3.1 Cysts

6.3.2 Blackheads

6.3.3 Others

6.4 Choroid plexus papilloma/Carcinoma

6.5 Boils

6.5.1 Furuncle or carbuncle

6.5.2 Cystic acne

6.5.3 Pilondial cyst

6.5.4 Others

6.6 Others

7. Global Hidradenitis Suppurativa Market By Treatment

7.1 Medications

7.1.1 Antibiotics

7.1.2 Antiandrogens

7.1.3 Immunosuppressive drugs

7.1.4 Hormones

7.1.5 Pain medication

7.1.6 Zinc supplements

7.1.7 Sulphones

7.1.8 Retinoids

7.1.8 Others

7.2 Surgery

7.2.1 Punch debridement

7.2.2. Incision and drainage

7.2.3 Surgical removal

7.2.4 Issue-sparing excision with electrosurgery

7.2.5 Others

7.3 Laser treatment

7.4 Photodynamic Therapy (PDT)

7.5 Others

8. Global Hidradenitis Suppurativa Market By End User

8.1 Hospitals

8.2 Dermatology clinics

8.3 Medical Research centers

8.4 Academic institutes

8.5 Others

9. Global Hidradenitis Suppurativa Market By Region

9.1 Introduction

9.2 America

9.2.1 North America US Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe Germany France Italy Spain UK Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia

9.4.1 China

9.4.2 India

9.4.3 Japan

9.4.4 South Korea

9.4.5 Rest of Asia

9.5 Pacific

9.6 Middle East and Africa

9.6.1 UAE

9.6.2 Saudi Arabia

9.6.3 Egypt

9.6.4 Rest of Middle East and Africa

10. Competitive landscape

11. Company profile

12. Conclusion

12.1 Key findings

12.1.1 From CEO’s viewpoint

12.1.2 Unmet needs of the market

12.2 Key companies to watch

12.3 Prediction of Hidradenitis Suppurativa Market

13. Appendix